1-4 of 4
Isabelle Marx
Close
Sort by
Journal Articles

A murine model to characterize the antithrombotic effect of molecules targeting human von Willebrand factor

Ana-Maria Navarrete, Caterina Casari, Paulette Legendre, Isabelle Marx, Jiun-Ruey Hu, Peter J. Lenting, Olivier D. Christophe, Cécile V. Denis
Journal: Blood
Blood (2012) 120 (13): 2723–2732.
https://doi.org/10.1182/blood-2012-03-420042
Published: 2012
Includes: Supplemental data
Journal Articles

Mutation and ADAMTS13-dependent modulation of disease severity in a mouse model for von Willebrand disease type 2B

Julie Rayes, Martine J. Hollestelle, Paulette Legendre, Isabelle Marx, Philip G. de Groot, Olivier D. Christophe, Peter J. Lenting, Cécile V. Denis
Journal: Blood
Blood (2010) 115 (23): 4870–4877.
https://doi.org/10.1182/blood-2009-11-254193
Published: 2010
Journal Articles

Altered thrombus formation in von Willebrand factor–deficient mice expressing von Willebrand factor variants with defective binding to collagen or GPIIbIIIa

Isabelle Marx, Olivier D. Christophe, Peter J. Lenting, Alain Rupin, Marie-Odile Vallez, Tony J. Verbeuren, Cécile V. Denis
Journal: Blood
Blood (2008) 112 (3): 603–609.
https://doi.org/10.1182/blood-2008-02-142943
Published: 2008
Journal Articles

Correction of the bleeding time in von Willebrand factor (VWF)–deficient mice using murine VWF

Peter J. Lenting, Philip G. de Groot, Simon F. De Meyer, Karen Vanhoorelbeke, Cynthia Pruss, David Lillicrap, Isabelle Marx, Cécile V. Denis
Journal: Blood
Blood (2007) 109 (5): 2267–2268.
https://doi.org/10.1182/blood-2006-10-054718
Published: 2007